Forma Therapeutics Holdings Inc. (FMTX): Price and Financial Metrics
GET POWR RATINGS... FREE!
FMTX Stock Price Chart Interactive Chart >
FMTX Price/Volume Stats
| Current price | $5.77 | 52-week high | $31.39 |
| Prev. close | $5.53 | 52-week low | $5.16 |
| Day low | $5.16 | Volume | 519,000 |
| Day high | $5.77 | Avg. volume | 521,289 |
| 50-day MA | $7.92 | Dividend yield | N/A |
| 200-day MA | $14.28 | Market Cap | 275.83M |
Forma Therapeutics Holdings Inc. (FMTX) Company Bio
Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA.
Latest FMTX News From Around the Web
Below are the latest news stories about Forma Therapeutics Holdings Inc that investors may wish to consider to help them evaluate FMTX as an investment opportunity.
Forma Therapeutics to Report Fourth Quarter and Year-end 2021 Financial Results and Provide Business Update on March 1, 2022WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics to Report Fourth Quarter and Year-end 2021 Financial Results and Provide Business Update on March 1, 2022 |
Top 10 Stock Picks of Srini Akkaraju and Michael Dybbs’ Samsara BioCapitalIn this article, we discuss the top 10 stock picks of Srini Akkaraju and Michael Dybbs’ Samsara BioCapital. You can skip our detailed analysis of Akkaraju and Dybbs’ history, investment philosophy, and hedge fund performance, and go directly to the Top 5 Stock Picks of Srini Akkaraju and Michael Dybbs’ Samsara BioCapital. Dr. Srinivas Akkaraju […] |
Forma Therapeutics to Present at 11th Annual SVB Leerink Healthcare ConferenceWATERTOWN, Mass., February 08, 2022--Forma Therapeutics to Present at 11th Annual SVB Leerink Healthcare Conference |
Forma Therapeutics Holdings Inc. (FMTX) Could Be Sitting On A GoldmineForma Therapeutics Holdings Inc. (NASDAQ:FMTX) concluded the trading at $11.14 on Friday, February 04 with a rise of 2.58% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $10.86 with its price kept floating in the range of $10.55 and $11.285 on … Forma Therapeutics Holdings Inc. (FMTX) Could Be Sitting On A Goldmine Read More » |
Forma Therapeutics Elects Esteemed Clinician and Industry Veteran Arturo Molina, M.D., to Board of Directors and R&D CommitteeWATERTOWN, Mass., January 13, 2022--Forma Therapeutics Elects Esteemed Clinician and Industry Veteran Arturo Molina, M.D., to Board of Directors and R&D Committee |
FMTX Price Returns
| 1-mo | -25.93% |
| 3-mo | -44.31% |
| 6-mo | -62.82% |
| 1-year | -79.44% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -59.42% |
| 2021 | -59.26% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...